Compare LMAT & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LMAT | TRIN |
|---|---|---|
| Founded | 1983 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2006 | 2020 |
| Metric | LMAT | TRIN |
|---|---|---|
| Price | $81.70 | $17.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $107.00 | $18.50 |
| AVG Volume (30 Days) | 232.8K | ★ 954.6K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | 1.24% | ★ 12.01% |
| EPS Growth | ★ 30.57 | N/A |
| EPS | ★ 1.42 | 0.85 |
| Revenue | ★ $249,602,000.00 | N/A |
| Revenue This Year | $10.79 | $31.52 |
| Revenue Next Year | $9.55 | $13.49 |
| P/E Ratio | $57.04 | ★ $19.95 |
| Revenue Growth | ★ 13.53 | N/A |
| 52 Week Low | $78.22 | $14.13 |
| 52 Week High | $118.01 | $18.90 |
| Indicator | LMAT | TRIN |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 53.17 |
| Support Level | $78.35 | $16.69 |
| Resistance Level | $83.15 | $17.31 |
| Average True Range (ATR) | 2.35 | 0.33 |
| MACD | -0.09 | 0.13 |
| Stochastic Oscillator | 33.22 | 89.58 |
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Trinity Capital Inc is an internally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, capital appreciation through investments across five distinct vertical markets. The company is focused on achieving its investment objective by operating as a specialty lending company that provides debt, including loans, equipment financings, and asset-based lending, to growth-oriented companies, including institutional investor-backed companies. Its investment portfolio mainly comprises private companies that have begun to have success selling their products to the market and need additional capital to expand their operations and sales.